SOPHARMA (SPH): Notification for merger of Achieve Lifesciences and Oncogenex - raport 44
Raport ESPI
UNI - EN REPORT No44/2017
We are pleased to announce that the next step in the process of merging Achieve Lifesciences and Oncogenex has been completed with the approval of the merger by the US SEC. OncoGenex will hold a special shareholder meeting on 1 August 2017 to vote the merger. Shortly after the newly formed entity will trade on NASDAQ stock exchange under the ticker symbol ACHV.
